Related Experiment Video
Updated: Sep 5, 2025

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Left ventricular geometry and electrocardiographic criteria in assessing left ventricular hypertrophy in sickle cell
Opeyemi O Oni1, Adewole A Adebiyi2, Akinyemi Aje2
1Department of Medicine, Bowen University Teaching Hospital, Ogbomoso, Oyo State, Nigeria.
Insights
Sickle cell anemia (SCA) causes abnormal left ventricular geometry, particularly eccentric left ventricular hypertrophy (LVH). Standard electrocardiogram criteria may need adjustment for SCA patients.
Area of Science:
- Cardiology
- Hematology
- Medical Imaging
Background:
- Left ventricular hypertrophy (LVH) is a known cardiovascular risk in sickle cell anemia (SCA).
- Determinants of abnormal left ventricular geometric patterns in SCA remain unclear.
Purpose of the Study:
- To investigate the prevalence and determinants of abnormal left ventricular geometric patterns in individuals with SCA.
- To compare LV geometry in SCA patients versus healthy controls.
Main Methods:
- Electrocardiography (ECG) and Echocardiography (ECHO) were performed on SCA patients and hemoglobin A (HbA) controls.
- Systemic hypertension was an exclusion criterion.
- Analysis included ECG voltages, durations, intervals, and echocardiographic measurements.
Main Results:
- SCA subjects exhibited significantly more abnormal LV geometric patterns than HbA controls (p=0.000).
- Eccentric LVH was more prevalent in SCA (p=0.000), while concentric LVH and remodeling were not significantly different.
- Sokolow-Lyon voltage sum emerged as an independent determinant of eccentric LVH in SCA patients.
Conclusions:
- Sickle cell anemia is a significant predisposing factor for abnormal LV geometry, especially eccentric LVH.
- Current electrocardiographic criteria for eccentric LVH may require re-evaluation in the SCA population.
Background:
Left ventricular hypertrophy (LVH) is recognized as a cardiovascular risk factor and is a known consequence of sickle cell anemia (SCA). Abnormal left ventricular geometric patterns have been described but the determinants have not been well elucidated.
Method:
Electrocardiography (ECG) and Echocardiography (ECHO) was done on subjects with SCA and hemoglobin A(HBA). Those with systemic hypertension were excluded. Voltages, durations, and intervals were measured as appropriate and recorded in a standard proforma. Analysis was made using a standard statistical software.
Results:
Eighty four people with SCA and 91 with HBA were recruited as cases and controls respectively. Subjects with SCA have more abnormal LV geometric patterns than those with HBA(p=0.000). Eccentric LVH(p=0.000) was more in SCA subjects while concentric LVH(p=0.054) and concentric remodeling(p=0.319) were not. Forty-one and fifty-two subjects with SCA and HBA respectively did ECGs. . Subjects with eccentric LVH had lower hip circumference, higher left atrial diameter, right atrial area, higher sokolow-lyon voltage sum, stroke volume and cardiac output. The Sokolow-Lyon voltage criteria at the traditional cut off point was not different between those with and without eccentric LVH. However, Sokolow-Lyon voltage criteria at a cut-off of ≥4.7mV detected eccentric LVH with a sensitivity of 60% and specificity of 83.3%.While Sokolow-Lyon voltage sum, stroke volume, right atrial area, and left atrial diameter correlated positively, pulse rate and hip circumference correlated inversely with eccentric LVH. Sokolow Lyon voltage sum was the independent determinant of eccentric LVH in this study.
Conclusion:
Sickle cell anemia predisposes to abnormal LV geometric patterns, especially eccentric LVH. There may be a need to review the electrocardiographic cut off points for defining eccentric LVH in the SCA populace.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology

